Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (GB:0QQD)
:0QQD
RESEARCH TOOLSreports
Total Valuation
Zimmer Biomet Holdings has a market cap or net worth of CHF15.06B. The enterprise value is CHF32.04B.
Market CapCHF15.06B
Enterprise ValueCHF32.04B
Share Statistics
Zimmer Biomet Holdings has 197,847,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding197,847,900
Owned by Insiders0.13%
Owned by Institutions24.75%
Financial Efficiency
Zimmer Biomet Holdings’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.68%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.68%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee451.68K
Profits Per Employee53.25K
Employee Count17,000
Asset Turnover0.36
Inventory Turnover0.98
Valuation Ratios
The current PE Ratio of Zimmer Biomet Holdings is 23.74. Zimmer Biomet Holdings’s PEG ratio is -4.13.
PE Ratio23.74
PS Ratio0.00
PB Ratio2.22
Price to Fair Value1.72
Price to FCF24.37
Price to Operating Cash Flow20.80
PEG Ratio-4.13
Income Statement
In the last 12 months, Zimmer Biomet Holdings had revenue of 7.68B and earned 903.80M in profits. Earnings per share was 4.45.
Revenue7.68B
Gross Profit5.49B
Operating Income1.29B
Pretax Income1.04B
Net Income903.80M
EBITDA2.25B
Earnings Per Share (EPS)4.45
Cash Flow
In the last 12 months, operating cash flow was 1.65B and capital expenditures -305.40M, giving a free cash flow of 1.35B billion.
Operating Cash Flow1.65B
Free Cash Flow1.35B
Free Cash Flow per Share6.82
Dividends & Yields
Zimmer Biomet Holdings pays an annual dividend of CHF0.772, resulting in a dividend yield of 1.02%
Dividend Per ShareCHF0.772
Dividend Yield1.02%
Payout Ratio12.15%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change-32.13%
50-Day Moving Average113.27
200-Day Moving Average113.82
Relative Strength Index (RSI)0.00
Average Volume (3m)14.00
Important Dates
Zimmer Biomet Holdings upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateMay 5, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateJun 26, 2025
Financial Position
Zimmer Biomet Holdings as a current ratio of 1.91, with Debt / Equity ratio of 47.39%
Current Ratio1.91
Quick Ratio0.99
Debt to Market Cap0.29
Net Debt to EBITDA2.52
Interest Coverage Ratio5.90
Taxes
In the past 12 months, Zimmer Biomet Holdings has paid 131.40M in taxes.
Income Tax131.40M
Effective Tax Rate0.13
Enterprise Valuation
Zimmer Biomet Holdings EV to EBITDA ratio is 12.05, with an EV/FCF ratio of 23.75.
EV to Sales3.53
EV to EBITDA12.05
EV to Free Cash Flow23.75
EV to Operating Cash Flow18.10
Balance Sheet
Zimmer Biomet Holdings has CHF1.38B in cash and marketable securities with $7.18B in debt, giving a net cash position of CHF5.79B billion.
Cash & Marketable SecuritiesCHF1.38B
Total Debt$7.18B
Net CashCHF5.79B
Net Cash Per ShareCHF29.27
Tangible Book Value Per Share-CHF5.28
Margins
Gross margin is 70.90%, with operating margin of 16.74%, and net profit margin of 11.77%.
Gross Margin70.90%
Operating Margin16.74%
Pretax Margin13.50%
Net Profit Margin11.77%
EBITDA Margin29.31%
EBIT Margin16.34%
Analyst Forecast
The average price target for Zimmer Biomet Holdings is CHF86.46, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetCHF86.46
Price Target Upside11.73% Upside
Analyst ConsensusHold
Analyst Count21
Revenue Growth Forecast―
EPS Growth Forecast―